This site is intended for UK Healthcare professionals only

Oncology Professional Care 2024
21-22 May at ExCeL London

Oncology Professional Care is the must-attend, multi-disciplinary event delivering free CPD-certified learning for the entire oncology community.

Are you a UK Healthcare professional?

We are unfortunately unable to allow patients to attend this event


Subpage Hero


Salivary Gland Cancer UK

Hall: N15 - N16 Stand: F36

We’re a charity for those with rare salivary gland cancers such as Adenoid Cystic Carcinoma, Acinic Cell Carcinoma, Mucoepidermoid Carcinoma... We are continuing to build an information and support network for people affected by, or treating, these conditions.

Through patient-clinician collaboration, we have formulated our 8 core aims, which drive our work:

1. To build support and information networks to:
a. Bring together those living with salivary gland cancers, giving them access to the latest information on their disease, and mutual support networks.
b. Raise awareness of salivary gland cancers, their symptoms and treatments amongst the general public and the clinical community.
c. Bring together the patient, clinical and research communities to help drive forward research and improvements in treatments.

2. Support advances in the understanding of the experience of living with and beyond these cancers, and the development of interventions to improve this experience.

3. Improve the rate of early diagnosis for salivary gland cancers.

4. Optimise the pathways to diagnosis.

5. Support the development of standardised guidelines for the management and surveillance of individual salivary gland cancers.

6. Understand the effectiveness of different types of radiotherapy for specific salivary gland cancers.

7. Support the development of surgical and radiotherapy treatments to deliver improved survivorship and quality-of-life post-treatment for salivary gland cancer patients.

8. Support the development of standard drug treatments for salivary gland cancers to improve life expectancy and survivorship by:
a. Supporting basic research into the biology of individual salivary gland cancers.
b. Supporting translational research that turns this basic knowledge into effective treatments.
c. Developing and pushing forward drug trials to test the effectiveness of both existing drugs, and those specifically developed to target a particular salivary gland cancer.


International House
International House 36-38 Cornhill
United Kingdom
Visit website

Contact Exhibitor


View all Exhibitors


Event Partner

Event Partner

Event Partner

Event Partner

Event Partner

Event partner

Event Partner

Event Partner

Event Partner

Event Partner

Event Partner

Media Partner